Combined training is the most effective training modality to improve aerobic capacity and blood pressure control in people requiring haemodialysis for end-stage renal disease: systematic review and network meta-analysis
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | SCAPINI, Katia B. | |
dc.contributor.author | BOHLKE, Maristela | |
dc.contributor.author | MORAES, Oscar A. | |
dc.contributor.author | RODRIGUES, Clarissa G. | |
dc.contributor.author | INACIO, Jose F. S. | |
dc.contributor.author | SBRUZZI, Graciele | |
dc.contributor.author | LEGUISAMO, Camila P. | |
dc.contributor.author | SANCHES, Iris C. | |
dc.contributor.author | TOURINHO FILHO, Hugo | |
dc.contributor.author | IRIGOYEN, Maria C. | |
dc.date.accessioned | 2019-02-21T17:30:07Z | |
dc.date.available | 2019-02-21T17:30:07Z | |
dc.date.issued | 2019 | |
dc.description.abstract | Questions: Do aerobic, resistance and combined exercise training improve aerobic capacity, arterial blood pressure and haemodialysis efficiency in people requiring haemodialysis for end-stage renal disease? Is one exercise training modality better than the others for improving these outcomes? Design: Systematic review with network meta-analysis of randomised trials. Participants: Adults requiring haemodialysis for end-stage renal disease. Intervention: Aerobic training, resistance training, combined training and control (no exercise or placebo). Outcome measures: Aerobic capacity, arterial blood pressure at rest, and haemodialysis efficiency. Results: Thirty-three trials involving 1254 participants were included. Direct meta-analyses were conducted first. Aerobic capacity improved significantly more with aerobic training (3.35 ml/kg/min, 95% CI 1.79 to 4.91) and combined training (5.00 ml/kg/min, 95% CI 3.50 to 6.50) than with control. Only combined training significantly reduced systolic (-9 mmHg, 95% CI - 13 to -4) and diastolic (-5 mmHg, 95% CI -6 to -3) blood pressure compared to control. Only aerobic training was superior to control for haemodialysis efficiency (Kt/V 0.11, 95% CI 0.02 to 0.20). However, when network meta-analysis was conducted, there were some important different findings. Both aerobic training and combined training again elicited greater improvements in aerobic capacity than control. For systolic blood pressure, combined training was superior to control. For diastolic blood pressure, combined training was superior to aerobic training and control. No modality was superior to control for haemodialysis efficiency. Combined training was ranked as the most effective treatment for aerobic capacity and arterial blood pressure. Conclusion: Combined training was the most effective modality to increase aerobic capacity and blood pressure control in people who require haemodialysis. This finding helps to fill the gap created by the lack of head-to-head comparisons of different modalities of exercise in people with end-stage renal disease. (C) 2018 Australian Physiotherapy Association. | eng |
dc.description.index | MEDLINE | eng |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - Brazil [467 300/2014-3, 457 581/2013-1, 307 138/2015-1] | |
dc.description.sponsorship | Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Brazil [074/2012-PVE, CsF - PveS 1170/2013] | |
dc.identifier.citation | JOURNAL OF PHYSIOTHERAPY, v.65, n.1, p.4-15, 2019 | |
dc.identifier.doi | 10.1016/j.jphys.2018.11.008 | |
dc.identifier.eissn | 1836-9561 | |
dc.identifier.issn | 1836-9553 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/30981 | |
dc.language.iso | eng | |
dc.publisher | AUSTRALIAN PHYSIOTHERAPY ASSOC | eng |
dc.relation.ispartof | Journal of Physiotherapy | |
dc.rights | openAccess | eng |
dc.rights.holder | Copyright AUSTRALIAN PHYSIOTHERAPY ASSOC | eng |
dc.subject | Chronic kidney failure | eng |
dc.subject | Renal dialysis | eng |
dc.subject | Exercise | eng |
dc.subject | Network meta-analysis | eng |
dc.subject | Physical therapy | eng |
dc.subject.other | quality-of-life | eng |
dc.subject.other | heart-rate-variability | eng |
dc.subject.other | intradialytic exercise | eng |
dc.subject.other | progressive exercise | eng |
dc.subject.other | phosphate removal | eng |
dc.subject.other | physical-exercise | eng |
dc.subject.other | controlled-trial | eng |
dc.subject.other | dialysis | eng |
dc.subject.other | program | eng |
dc.subject.other | rehabilitation | eng |
dc.subject.wos | Orthopedics | eng |
dc.subject.wos | Rehabilitation | eng |
dc.title | Combined training is the most effective training modality to improve aerobic capacity and blood pressure control in people requiring haemodialysis for end-stage renal disease: systematic review and network meta-analysis | eng |
dc.type | article | eng |
dc.type.category | review | eng |
dc.type.version | publishedVersion | eng |
dspace.entity.type | Publication | |
hcfmusp.author.external | BOHLKE, Maristela:Univ Catolica Pelotas, Pelotas, RS, Brazil | |
hcfmusp.author.external | RODRIGUES, Clarissa G.:Inst Cardiol Rio Grande Do Sul, Porto Alegre, RS, Brazil | |
hcfmusp.author.external | INACIO, Jose F. S.:Inst Cardiol Rio Grande Do Sul, Porto Alegre, RS, Brazil | |
hcfmusp.author.external | SBRUZZI, Graciele:Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil | |
hcfmusp.author.external | LEGUISAMO, Camila P.:Univ Passo Fundo, Passo Fundo, RS, Brazil | |
hcfmusp.author.external | SANCHES, Iris C.:Univ Sao Judas Tadeu, Sao Paulo, Brazil | |
hcfmusp.author.external | TOURINHO FILHO, Hugo:Univ Sao Paulo, Ribeirao Preto Sch Phys Educ & Sports, Sao Paulo, Brazil | |
hcfmusp.citation.scopus | 45 | |
hcfmusp.contributor.author-fmusphc | KATIA BILHAR SCAPINI | |
hcfmusp.contributor.author-fmusphc | OSCAR ALBUQUERQUE DE MORAES | |
hcfmusp.contributor.author-fmusphc | MARIA CLAUDIA COSTA IRIGOYEN | |
hcfmusp.description.beginpage | 4 | |
hcfmusp.description.endpage | 15 | |
hcfmusp.description.issue | 1 | |
hcfmusp.description.volume | 65 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 30581137 | |
hcfmusp.origem.scopus | 2-s2.0-85058713175 | |
hcfmusp.origem.wos | WOS:000454723900003 | |
hcfmusp.publisher.city | ST KILDA | eng |
hcfmusp.publisher.country | AUSTRALIA | eng |
hcfmusp.relation.reference | Abreu CC, 2017, LIFE SCI, V188, P192, DOI 10.1016/j.lfs.2017.09.007 | eng |
hcfmusp.relation.reference | Afshar R, 2010, Indian J Nephrol, V20, P185, DOI 10.4103/0971-4065.73442 | eng |
hcfmusp.relation.reference | Akiba T, 1995, ARTIF ORGANS, V19, P1262, DOI 10.1111/j.1525-1594.1995.tb02297.x | eng |
hcfmusp.relation.reference | CARNEY RM, 1987, NEPHRON, V47, P194, DOI 10.1159/000184490 | eng |
hcfmusp.relation.reference | Cheema B, 2007, AM J KIDNEY DIS, V50, P574, DOI 10.1053/j.ajkd.2007.07.005 | eng |
hcfmusp.relation.reference | Cheema B, 2007, J AM SOC NEPHROL, V18, P1594, DOI 10.1681/ASN.2006121329 | eng |
hcfmusp.relation.reference | Deligiannis A, 1999, INT J CARDIOL, V70, P253, DOI 10.1016/S0167-5273(99)00090-X | eng |
hcfmusp.relation.reference | Deligiannis A, 1999, AM J CARDIOL, V84, P197, DOI 10.1016/S0002-9149(99)00234-9 | eng |
hcfmusp.relation.reference | DePaul V, 2002, AM J KIDNEY DIS, V40, P1219, DOI 10.1053/ajkd.2002.36887 | eng |
hcfmusp.relation.reference | Dobsak P, 2012, ARTIF ORGANS, V36, P71, DOI 10.1111/j.1525-1594.2011.01302.x | eng |
hcfmusp.relation.reference | Farese S, 2008, AM J KIDNEY DIS, V52, P745, DOI 10.1053/j.ajkd.2008.03.017 | eng |
hcfmusp.relation.reference | Frey S, 1999, J Ren Nutr, V9, P71, DOI 10.1016/S1051-2276(99)90003-1 | eng |
hcfmusp.relation.reference | Frih B, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00288 | eng |
hcfmusp.relation.reference | Goldberg A P, 1983, Kidney Int Suppl, V16, pS303 | eng |
hcfmusp.relation.reference | GOLDBERG AP, 1986, NEPHRON, V42, P311, DOI 10.1159/000183694 | eng |
hcfmusp.relation.reference | Groussard C, 2015, APPL PHYSIOL NUTR ME, V40, P550, DOI 10.1139/apnm-2014-0357 | eng |
hcfmusp.relation.reference | HARTER HR, 1985, MED CLIN N AM, V69, P159, DOI 10.1016/S0025-7125(16)31063-X | eng |
hcfmusp.relation.reference | Heiwe S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003236.pub2 | eng |
hcfmusp.relation.reference | Higgins JPT, 2011, COCHRANE HDB SYSTEMA, DOI 10.1002/9780470712184 | eng |
hcfmusp.relation.reference | Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765 | eng |
hcfmusp.relation.reference | Iberati A, 2009, BMJ-BRIT MED J, V339, pb2700, DOI 10.1136/BMJ.B2700 | eng |
hcfmusp.relation.reference | Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X | eng |
hcfmusp.relation.reference | Koh KP, 2010, AM J KIDNEY DIS, V55, P88, DOI 10.1053/j.ajkd.2009.09.025 | eng |
hcfmusp.relation.reference | Konstantinidou E, 2002, J REHABIL MED, V34, P40, DOI 10.1080/165019702317242695 | eng |
hcfmusp.relation.reference | Kopple JD, 2007, J AM SOC NEPHROL, V18, P2975, DOI 10.1681/ASN.2006070794 | eng |
hcfmusp.relation.reference | Kouidi E, 1997, NEPHRON, V77, P152, DOI 10.1159/000190266 | eng |
hcfmusp.relation.reference | Kouidi E, 2010, EUR J CARDIOV PREV R, V17, P160, DOI 10.1097/HJR.0b013e32833188c4 | eng |
hcfmusp.relation.reference | Kouidi EJ, 2009, AM J KIDNEY DIS, V54, P511, DOI 10.1053/j.ajkd.2009.03.009 | eng |
hcfmusp.relation.reference | Liao MT, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004134 | eng |
hcfmusp.relation.reference | Mohseni Raheleh, 2013, Oman Med J, V28, P345, DOI 10.5001/omj.2013.99 | eng |
hcfmusp.relation.reference | Molsted S, 2004, NEPHRON CLIN PRACT, V96, P76, DOI 10.1159/000076744 | eng |
hcfmusp.relation.reference | Moros M T, 1995, Rev Med Univ Navarra, V39, P136 | eng |
hcfmusp.relation.reference | O'Hare AM, 2003, AM J KIDNEY DIS, V41, P447, DOI 10.1053/ajkd.2003.50055 | eng |
hcfmusp.relation.reference | Olsen MH, 2015, LANCET, V386, P637, DOI 10.1016/S0140-6736(15)61178-3 | eng |
hcfmusp.relation.reference | Orcy R, 2014, HEMODIAL INT, V18, P450, DOI 10.1111/hdi.12123 | eng |
hcfmusp.relation.reference | Ouzouni S, 2009, CLIN REHABIL, V23, P53, DOI 10.1177/0269215508096760 | eng |
hcfmusp.relation.reference | Painter P, 2002, AM J KIDNEY DIS, V39, P257, DOI 10.1053/ajkd.2002.30544 | eng |
hcfmusp.relation.reference | Parsons TL, 2004, CLIN NEPHROL, V61, P261 | eng |
hcfmusp.relation.reference | Petraki M, 2008, CLIN NEPHROL, V70, P210 | eng |
hcfmusp.relation.reference | Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1 | eng |
hcfmusp.relation.reference | Reboredo Maycon de Moura, 2010, J Bras Nefrol, V32, P367 | eng |
hcfmusp.relation.reference | Reboredo MM, 2015, EUR J PREV CARDIOL, V22, P912, DOI 10.1177/2047487314543079 | eng |
hcfmusp.relation.reference | Reboredo MM, 2011, ARCH PHYS MED REHAB, V92, P2018, DOI 10.1016/j.apmr.2011.07.190 | eng |
hcfmusp.relation.reference | Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150 | eng |
hcfmusp.relation.reference | Saran R, 2004, AM J KIDNEY DIS, V44, pS47, DOI 10.1053/j.ajkd.2004.08.011 | eng |
hcfmusp.relation.reference | Schwingshackl L, 2014, DIABETOLOGIA, V57, P1789, DOI 10.1007/s00125-014-3303-z | eng |
hcfmusp.relation.reference | Schwingshackl L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082853 | eng |
hcfmusp.relation.reference | Sheng KX, 2014, AM J NEPHROL, V40, P478, DOI 10.1159/000368722 | eng |
hcfmusp.relation.reference | Sietsema KE, 2004, KIDNEY INT, V65, P719, DOI 10.1111/j.1523-1755.2004.00411.x | eng |
hcfmusp.relation.reference | Stack AG, 2005, AM J KIDNEY DIS, V45, P690, DOI 10.1053/j.ajkd.2004.12.013 | eng |
hcfmusp.relation.reference | Tentori F, 2010, NEPHROL DIAL TRANSPL, V25, P3050, DOI 10.1093/ndt/gfq138 | eng |
hcfmusp.relation.reference | Thompson S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012085 | eng |
hcfmusp.relation.reference | Toussaint ND, 2008, HEMODIAL INT, V12, P254, DOI 10.1111/j.1542-4758.2008.00262.x | eng |
hcfmusp.relation.reference | Tsuyuki K, 2003, THER APHER DIAL, V7, P461, DOI 10.1046/j.1526-0968.2003.00084.x | eng |
hcfmusp.relation.reference | Vaithilingam I, 2004, AM J KIDNEY DIS, V43, P85, DOI 10.1053/j.ajkd.2003.09.016 | eng |
hcfmusp.relation.reference | van Vilsteren MCBA, 2005, NEPHROL DIAL TRANSPL, V20, P141, DOI 10.1093/ndt/gfh560 | eng |
hcfmusp.relation.reference | Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029 | eng |
hcfmusp.relation.reference | Wilund KR, 2010, NEPHROL DIAL TRANSPL, V25, P2695, DOI 10.1093/ndt/gfq106 | eng |
hcfmusp.relation.reference | Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3 | eng |
hcfmusp.scopus.lastupdate | 2024-05-10 | |
relation.isAuthorOfPublication | e8906456-b5ea-43c3-a7cf-4cdc353e7ab0 | |
relation.isAuthorOfPublication | 9fdfbab1-abf7-4068-ad93-b6a123539c10 | |
relation.isAuthorOfPublication | 124821b6-302b-4392-8a9a-b693916724e1 | |
relation.isAuthorOfPublication.latestForDiscovery | e8906456-b5ea-43c3-a7cf-4cdc353e7ab0 |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- art_SCAPINI_Combined_training_is_the_most_effective_training_modality_2019.PDF
- Tamanho:
- 655 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)